.svg){kind=small}
May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
Alternative Medicine Association / AMA concentrated 71.99% of May-2026 sales in Flower, where year-over-year sales fell 9.74% while month-over-month sales grew 5.43%; meanwhile, Pre-Roll held 13.93% share with a 42.74% YoY decline and a 3.19% MoM dip. Concentrates accounted for 9.01% share with a 45.47% YoY decline but a 7.81% MoM increase, and Vapor Pens at 5.08% share dropped 67.74% YoY even as they rose 12.58% MoM. With Flower ranked 3 in Nevada, the mix shows a defensive tilt toward the top category and selective near-term rebounds in smaller formats, implying the brand is leaning on its Flower position while testing momentum recovery in inhalables despite double‑digit YoY contractions.
The combination of a 12.49% YoY rise in average price alongside a 26.65% YoY decline in brand sales suggests price-led pressure that amplified category-specific downturns, particularly the 67.74% YoY drop in Vapor Pens and the 45.47% YoY decline in Concentrates. However, the 12.58% MoM lift in Vapor Pens and the 7.81% MoM lift in Concentrates, against a 5.43% MoM gain in Flower and a 3.19% MoM pullback in Pre-Roll, indicates emerging elasticity in higher-potency or convenience segments while value-sensitive Pre-Roll lags. The pattern implies AMA’s positioning is anchored in Flower scale and rank 3 status, but near-term share defense likely depends on nurturing the MoM upticks in Vapor Pens and Concentrates to offset Pre-Roll weakness and mitigate the 58.89% 24‑month sales erosion.
Competitive Landscape
Alternative Medicine Association / AMA sits at rank #3 in NV Flower in May 2026, a 1-position improvement from rank #4 year over year, but down 2 positions from its peak at #1 in February 2026; this mirrors a three-month slide from #1 in March 2026 to #3 in May 2026, indicating near-term loss of lead despite YoY climb. Against competitors, STIIIZY holds #1 with no YoY rank change while RYTHM moved up from #3 to #2, and Redwood surged from #54 to #5 with a 917.6% YoY sales increase; by contrast, Good Green improved rank from #5 to #4 despite a 22.8% YoY sales decline. The pattern implies AMA’s competitive position is tightening: mid-term ranking improved year over year, but recent rank erosion from #1 to #3 within three months suggests retention and velocity now matter more than acquisition for sustaining a top-three foothold.
Notable Products
Scoby (3.5g) posted the largest movement with a +59.7% month-over-month gain in May 2026, helping it reach rank 3 while Truffle Skunk (14g) fell -30.1% to rank 8. Kush Cake Pre-Roll (1g) declined -26.5% at rank 7 as Pixie Dust (14g) dropped -32.2% to rank 9, indicating that value in smaller Flower pack sizes is outpacing larger formats. With Flower occupying 7 of the top 10 positions and Scoby (14g) and Kush Cake (14g) sitting at ranks 1 and 2, the product mix is consolidating around core Flower strains even as Pre-Roll volatility persists. This pattern implies Alternative Medicine Association / AMA is skewing toward flagship Flower SKUs and smaller format upsell paths rather than sustaining breadth in large-format or Pre-Roll offerings.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
